Category - Developments

Developments

IntelGenx partner receives marketing clearance for RIZAPORT in Spain

IntelGenx’s (TSXV:IGX; OTCQX:IGXT) commercialization partner, Groupo Juste, which is now part of Exceltis Healthcare, has received national marketing authorization for RIZAPORT 10 mg from the Spanish Agency of Medicines...

October 31, 2018

Developments

Physicians Endoscopy adds three GI ambulatory partnerships

Closely-held Physicians Endoscopy (PE) announced the addition of three GI ambulatory surgery center (ASC) partnerships that were finalized between July and September of 2018. The partnerships increase PE’s...

October 30, 2018

Developments

ContraVir Pharma completes dosing in CRV431 drug-drug interaction study

ContraVir Pharmaceuticals (NASDAQ:CTRV) completed dosing of the last cohort of healthy subjects for its CRV431 drug-drug interaction (DDI) study. The single-dose crossover study evaluated subjects co-treated with...

October 30, 2018

Developments

Knight Therapeutics launches Titan Pharma’s Probuphine in Canada

Knight Therapeutics (TSX:GUD) announced the Canadian launch of Titan Pharmaceuticals’ (NASDAQ:TTNP) Probuphine subdermal implant of buprenorphine hydrochloride for the management of opioid dependence in patients...

October 29, 2018

Developments

Lobo Cube DNA testing device for safer cannabis use gaining major media attention

An Oct. 26 article on the Washington Post web site discusses job openings in Canada’s legalized cannabis sector, highlighting an Ontario government policy advisor who left his job to join Lobo Genetics as its director...

October 26, 2018

Developments

Mati Therapeutics expands IP portfolio to 114 patents in 19 patent families

Closely-held Mati Therapeutics’ international patent portfolio has grown to 114 issued patents, including a recently granted U.S. patent, which covers a drug delivery system for administering an ophthalmic drug through...

October 24, 2018

Developments

Health Canada clears Scientus Pharma to make cannabis soft gel capsules and oils

Closely-held Scientus Pharma received Health Canada authorization to produce cannabis soft gel capsules and oils at its state-of-the-art commercial production facility in Whitby, Ontario. “At Scientus Pharma, our main...

October 22, 2018

Developments

Scientific American article explores why some doctors reject tools that make their jobs easier

In the latest edition of Scientific American online, Dr. Gina Siddiqui, an emergency room doctor at Yale New Haven Hospital, discusses why physicians have incorrectly feared that new technology would make their jobs...

October 17, 2018

Developments

Ortho RTi presents rotator cuff repair study at SICOT orthopedic congress

Ortho Regenerative Technologies (CSE:ORTH) presented a poster entitled, “Freeze-dried [Ortho-R] in Platelet-rich Plasma in Sheep Model of Rotator Cuff Repair,” at the SICOT Orthopaedic World Congress in Montreal. The...

October 11, 2018

Developments

CHF Solutions in collaboration with NI Medical on fluid overload

CHF Solutions (NASDAQ:CHFS) and NI Medical are collaborating to explore potential clinical synergies between CHF’s Aquadex FlexFlow System and NI Medical’s NICaS Hemodynamic Navigator to assess patient’s fluid volume...

October 11, 2018

Category - Developments

IntelGenx partner receives marketing clearance for RIZAPORT in Spain

Physicians Endoscopy adds three GI ambulatory partnerships

ContraVir Pharma completes dosing in CRV431 drug-drug interaction study

Knight Therapeutics launches Titan Pharma’s Probuphine in Canada

Lobo Cube DNA testing device for safer cannabis use gaining major media attention

Mati Therapeutics expands IP portfolio to 114 patents in 19 patent families

Health Canada clears Scientus Pharma to make cannabis soft gel capsules and oils

Scientific American article explores why some doctors reject tools that make their jobs easier

Ortho RTi presents rotator cuff repair study at SICOT orthopedic congress

CHF Solutions in collaboration with NI Medical on fluid overload

General

More